As a measure of genetic susceptibility to prostate cancer, the PRS could potentially be an effective tool to identify men across diverse populations at higher risk of developing prostate cancer and allow them to make more informed decisions regarding at what age(s) and how frequently to undergo prostate-specific antigen (PSA) screening. Here, KLK3 is linked to prostate carcinoma.